We treated the CML cell lines with GI and GA in combination with the BCR::ABL1 TKIs based on methods proposed by Chou and Talalay [21] and measured proliferation. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.